サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390562

メタゲノミクス市場：世界の産業動向、シェア、規模、成長、機会、2023年～2028年予測

Metagenomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
メタゲノミクス市場：世界の産業動向、シェア、規模、成長、機会、2023年～2028年予測
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界のメタゲノミクス市場規模は2022年に5億540万米ドルに達しました。今後、IMARC Groupは、市場は2028年までに9億6,600万米ドルに達し、2022年から2028年の間に11.40%の成長率（CAGR）を示すと予測しています。

メタゲノミクスは、自然環境における微生物ゲノムの研究を指します。生態学、進化、多様性を研究するためにゲノムのクローニングを行い、それによって個々の種の分離や実験室での培養の必要性を回避します。メタゲノミクスは、科学的洞察を得るためにシークエンシングとバイオインフォマティクスの技術を使用し、水、土壌、人間の排泄物などの環境サンプルから得られたデオキシリボ核酸（DNA）を分析する分子ツールとして利用されます。サンプルはさらに、塩基配列の読み取り、遺伝子予測、ビニング、機能アノテーションによって処理されます。得られた知見は、感染症の診断、環境修復、腸内微生物の特性解析、バイオ燃料の開発などに利用されます。

メタゲノミクス市場の動向：

下痢、インフルエンザ、B型肝炎、HIV/AIDSなど、ウイルスによる感染症が世界中で流行していることが、市場成長を促進する主な要因の一つです。さらに、髄膜炎や脳炎などの神経感染症をタイムリーに診断するための効果的なソリューションに対する需要の高まりが、市場の成長を後押ししています。これに伴い、メタゲノミクスは、食中毒の発生につながる可能性のある細菌性病原体の特定にも役立ち、これがさらに市場の成長に寄与しています。従来から使用されている技術と比較して、メタゲノミクスではプレシークエンシングのステップ数が少なくて済み、長い読み取り値の信憑性が高まり、読み取り精度が高いです。さらに、次世代シーケンスサービスの開発など、さまざまな技術的進歩が他の成長促進要因として作用しています。これらのソリューションはデータ解析ソフトウェアと統合され、より迅速なデータ解析とサンプル処理が可能です。その他の要因としては、ライフサイエンス分野における広範な研究開発（R&D）活動や、持続可能な農産物の製造におけるメタゲノミクスの利用拡大などが挙げられ、市場の成長を後押しすると予想されます。

本レポートで扱う主な質問

  • 世界のメタゲノミクス市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界のメタゲノミクス市場に与えた影響は？
  • 主要な地域市場は？
  • 製品別の市場内訳は？
  • 技術別の市場内訳は？
  • 用途別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界のメタゲノミクス市場の構造と主要企業は？
  • 業界における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のメタゲノミクス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 機器・ソフトウェア
    • 市場動向
    • 市場予測
  • 消耗品
    • 市場動向
    • 市場予測

第7章 市場内訳：技術別

  • シーケンス
    • 市場動向
    • 市場予測
  • バイオインフォマティクス
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • 感染症診断
    • 市場動向
    • 市場予測
  • 環境修復
    • 市場動向
    • 市場予測
  • 腸内微生物の特性解析
    • 市場動向
    • 市場予測
  • バイオテクノロジー
    • 市場動向
    • 市場予測
  • バイオ燃料
    • 市場動向
    • 市場予測
  • 農業
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Enterome
    • Eurofins Scientific
    • F. Hoffmann-La Roche AG（Roche Holding AG）
    • Illumina Inc
    • Novogene Co. Ltd.
    • Oxford Nanopore Technologies Limited
    • Pacific Biosciences of California Inc.
    • PerkinElmer Inc.
    • QIAGEN N.V.
    • Swift Biosciences Inc.（Danaher Corporation）
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Metagenomics Market: Major Drivers and Challenges
  • Figure 2: Global: Metagenomics Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Metagenomics Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Metagenomics Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Metagenomics Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Metagenomics Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Metagenomics (Instruments and Software) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Metagenomics (Instruments and Software) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Metagenomics (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Metagenomics (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Metagenomics (Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Metagenomics (Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Metagenomics (Bioinformatics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Metagenomics (Bioinformatics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Metagenomics (Infectious Disease Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Metagenomics (Infectious Disease Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Metagenomics (Environmental Remediation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Metagenomics (Environmental Remediation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Metagenomics (Gut Microbe Characterization) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Metagenomics (Gut Microbe Characterization) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Metagenomics (Biotechnology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Metagenomics (Biotechnology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Metagenomics (Biofuel) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Metagenomics (Biofuel) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Metagenomics (Agriculture) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Metagenomics (Agriculture) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Metagenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Metagenomics Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Metagenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Metagenomics Industry: SWOT Analysis
  • Figure 78: Global: Metagenomics Industry: Value Chain Analysis
  • Figure 79: Global: Metagenomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Metagenomics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Metagenomics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Metagenomics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Metagenomics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Metagenomics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Metagenomics Market: Competitive Structure
  • Table 7: Global: Metagenomics Market: Key Players
目次
Product Code: SR112023A4344

Abstract

The global metagenomics market size reached US$ 505.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 966.0 Million by 2028, exhibiting a growth rate (CAGR) of 11.40% during 2022-2028.

Metagenomics refers to the study of microbial genomes in the natural environment. It involves cloning of the genome to study the ecology, evolution and diversity, thereby bypassing the need for isolation and laboratory cultivation of individual species. Metagenomics uses sequencing and bioinformatics technologies to obtain scientific insights and is utilized as a molecular tool for analyzing the deoxyribonucleic acid (DNA) acquired from the environmental samples through water, soil and human waste. The samples are further processed through sequence reading, gene prediction, binning and functional annotation. The insights are used to diagnose infectious diseases, environmental remediation, gut microbe characterization and the development of biofuels.

Metagenomics Market Trends:

The increasing prevalence of virus-induced infections, such as diarrhea, influenza, hepatitis B, and HIV/AIDS, across the globe, is among the key factors driving the market growth. Moreover, the rising demand for effective solutions for the timely diagnosis of neuroinfectious diseases, such as meningitis and encephalitis, is providing a thrust to the market growth. In line with this, metagenomics also aids in identifying bacterial pathogens that can lead to foodborne disease outbreaks, which is further contributing to the growth of the market. In comparison to the traditionally used technologies, metagenomics requires a lesser number of pre-sequencing steps, enhances the authenticity of long readings and offers high read accuracy. Additionally, various technological advancements, such as the development of next-generation sequencing services, are acting as other growth-inducing factors. These solutions are integrated with data analysis software for faster data analysis and sample processing. Other factors, including extensive research and development (R&D) activities in the field of life sciences, along with the increasing utilization of metagenomics for manufacturing sustainable agricultural products, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global metagenomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, technology and application.

Breakup by Product:

Instruments and Software

Consumables

Breakup by Technology:

Sequencing

Bioinformatics

Breakup by Application:

Infectious Disease Diagnosis

Environmental Remediation

Gut Microbe Characterization

Biotechnology

Biofuel

Agriculture

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc, Enterome, Eurofins Scientific, F. Hoffmann-La Roche AG (Roche Holding AG), Illumina Inc, Novogene Co. Ltd., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN N.V., Swift Biosciences Inc. (Danaher Corporation) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global metagenomics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global metagenomics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global metagenomics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Metagenomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments and Software
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Sequencing
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bioinformatics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Disease Diagnosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Environmental Remediation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Gut Microbe Characterization
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Biotechnology
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Biofuel
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Agriculture
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Enterome
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Eurofins Scientific
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 F. Hoffmann-La Roche AG (Roche Holding AG)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Illumina Inc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Novogene Co. Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Oxford Nanopore Technologies Limited
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pacific Biosciences of California Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 PerkinElmer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 QIAGEN N.V.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Swift Biosciences Inc. (Danaher Corporation)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis